Longterm safety and efficacy of recombinant human parathyroid hormone (rhPTH[1-84]) for the treatment of adults with hypoparathyroidism: Interim data from the race study

Authors
Category Primary study
JournalEndocrine Reviews
Year 2014
This article has no abstract
Epistemonikos ID: 446e5f06ee7f1673823a775181f6de00200bc9df
First added on: Feb 07, 2025